Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00061529
Status:
COMPLETED
Last Update Posted:
2008-08-05
First Post:
2003-05-28
Brief Title:
A Phase III Study of Brimonidine Tartrate Ophthalmic Solution 015 in Patients With Open-Angle Glaucoma or Ocular Hypertension
Sponsor:
Alcon Research
Organization:
Alcon Research
Study Overview
Official Title:
A Phase III Study of Brimonidine Tartrate Ophthalmic Solution 015 in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status:
COMPLETED
Status Verified Date:
2008-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective of this study is to compare the safety and efficacy of Brimonidine Tartrate Ophthalmic Solution 015 in patients with open-angle glaucoma or ocular hypertension
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None